Key Takeaways
- • Palliser Capital, a shareholder of Italian pharmaceutical company Recordati, has confirmed it does not support the recent €53 per share offer from CVC and GBL, according to PE Hub.
- • The story also reports that Permira is considering a sale of Octus valued at approximately $3.5 billion to the London Stock Exchange Group.
- • The source article is largely a paywall teaser, so the full details of the Octus deal and Palliser's objections were not available for this summary.
Summary
Palliser Capital, a shareholder of Recordati, has confirmed it does not support the recent offer of €53 per share from CVC and GBL, according to PE Hub. The disclosure adds to shareholder resistance to the bid for the Italian pharmaceutical group, with Palliser raising further concerns about the transaction.
The same headline reports that Permira is weighing a sale of Octus, a transaction valued at approximately $3.5 billion, to the London Stock Exchange Group. The primary source does not provide further detail on deal terms, timing, or the status of negotiations.
The available reporting is limited to the publisher summary and opening paragraph, with the remainder of the article behind a registration wall. Readers seeking the full analysis of Palliser's objections and the terms of the proposed Octus sale should consult the original PE Hub article.
The same headline reports that Permira is weighing a sale of Octus, a transaction valued at approximately $3.5 billion, to the London Stock Exchange Group. The primary source does not provide further detail on deal terms, timing, or the status of negotiations.
The available reporting is limited to the publisher summary and opening paragraph, with the remainder of the article behind a registration wall. Readers seeking the full analysis of Palliser's objections and the terms of the proposed Octus sale should consult the original PE Hub article.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.